Digest Network Come funziona
Network
/
Società
Ka
Non verificato

Kallyope

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

6 comunicati stampa

Guarda tutti i comunicati
05/03/2026
Eventi
Scienza
Tecnica
Tecnologie Varie
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Kallyope to Present Phase 2b Study Results for Elismetrep for the Acute Treatment of Migraine at the 2026 American Academy of Neurology Annual Meeting
Fonte
Kallyope
Emittente
Business Wire
1.00
0
07/01/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Kallyope Announces 2026 Strategic Priorities for Migraine and Metabolism Portfolio Based on Novel Neural Circuits Platform
Fonte
Kallyope
Emittente
Business Wire
1.00
0
18/12/2025
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Kallyope
Emittente
Business Wire
1.00
0
17/12/2025
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Kallyope
Emittente
Business Wire
1.00
0
08/12/2025
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine
Fonte
Kallyope
Emittente
Business Wire
1.00
0
10/09/2024
Mercato del lavoro
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Kallyope Announces License Agreement with Novo Nordisk
Fonte
Kallyope
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0